IDH1 and intrahepatic cholangiocarcinoma: To further understand the mechanisms underlying the anti-ICC activities of aloperine, we conducted metabonomic and molecular biological experiments, which revealed that aloperine had preferential antitumor effects in ICC cells harboring the mutant IDH1 by decreasing D-2HG.